Taxane Compounds for Resistant Tuberculosis Strains
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for tuberculosis are hindered by increasing drug resistance in Mycobacterium tuberculosis strains, necessitating the development of novel compounds with effective anti-tuberculosis activity against both sensitive and resistant strains.
Innovation Solution
Development of taxane compounds with specific structural formulas (I, II, and III) that incorporate carbocyclic or heterocyclic aromatic rings, capable of targeting Mycobacterium tuberculosis, including administration methods and pharmaceutical compositions for therapeutic efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional antibiotics are used to treat tuberculosis, then treatment is effective against sensitive strains, but drug resistance develops in resistant strains
Solution Approach 1:
The patent modifies the chemical structure of taxane compounds by changing parameters such as substituting aromatic rings at specific positions (R1-R8), adjusting side chain lengths (n=1-3), and modifying functional groups (R9, R10, R11). These structural parameter changes create novel compounds that bypass resistance mechanisms while maintaining anti-tuberculosis efficacy against both sensitive and resistant strains.
Solution Approach 2:
The invention creates composite molecular structures by combining taxane core structures with various aromatic ring systems (carbocyclic or heterocyclic) and different side chain configurations. This composite approach generates a diverse library of compounds (formulas I, II, and III) that collectively address the challenge of drug resistance through multiple structural variants.
2Adaptability or versatility
If taxane compounds are developed for anti-tuberculosis activity, then effectiveness against resistant strains improves, but compound structure and synthesis complexity increases
Solution Approach 1:
The patent segments the taxane molecule into distinct functional regions with specific substituents (R1-R11) that can be independently modified. This segmentation allows systematic variation of structural elements (aromatic rings at different positions, different side chains) to optimize activity against resistant strains while managing synthesis complexity through modular approaches.
Solution Approach 2:
The taxane core structure serves as a universal platform that can accommodate multiple different aromatic ring systems and side chain configurations. This multi-functionality allows a single core structure to generate multiple active compounds against different strain types, reducing the need to develop entirely new molecular frameworks for each application.
Data Source
AI summary
The present invention relates to compounds having the formula (I):